Qube Research & Technologies Ltd - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,341,333
-71.3%
74,025
-57.9%
0.01%
-75.0%
Q1 2023$4,678,275
+214.0%
175,875
+128.2%
0.02%
+150.0%
Q4 2022$1,489,763
+165.1%
77,070
+186.5%
0.01%
+166.7%
Q3 2022$562,000
+420.4%
26,901
+99.9%
0.00%
+200.0%
Q2 2022$108,00013,4590.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 339,160$5,881,034100.00%
CHI Advisors LLC 3,014,199$52,266,21120.72%
TRV GP IV, LLC 2,132,867$36,983,91413.93%
GREAT POINT PARTNERS LLC 1,755,184$30,434,8915.54%
First Light Asset Management, LLC 2,933,260$50,862,7284.83%
Deep Track Capital, LP 5,500,000$95,370,0003.68%
Casdin Capital, LLC 1,577,108$27,347,0533.03%
Fernwood Investment Management, LLC 379,702$6,584,0332.37%
Redmile Group, LLC 2,678,099$46,438,2372.21%
SILVERARC CAPITAL MANAGEMENT, LLC 250,409$4,342,0921.32%
View complete list of PLIANT THERAPEUTICS INC shareholders